相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Potential neuroprotective effect of ibuprofen, insights from the mice model of Parkinson's disease
Maciej Świątkiewicz et al.
Pharmacological Reports (2014)
Oxidative damage to macromolecules in human Parkinson disease and the rotenone model
Laurie H. Sanders et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Pathogenesis of Parkinson's Disease
Etienne C. Hirsch et al.
MOVEMENT DISORDERS (2013)
Testing NF-κB-based Therapy in Hemiparkinsonian Monkeys
Susanta Mondal et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease
Louise M. Collins et al.
NEUROPHARMACOLOGY (2012)
Imaging of microglia in patients with neurodegenerative disorders
Marios Politis et al.
FRONTIERS IN PHARMACOLOGY (2012)
Acute but not chronic administration of pioglitazone promoted behavioral and neurochemical protective effects in the MPTP model of Parkinson's disease
Janaina K. Barbiero et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
NSAID use and risk of Parkinson disease: a population-based case-control study
C. Becker et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Parkinson's Disease
Angelika D. Manthripragada et al.
NEUROEPIDEMIOLOGY (2011)
Use of ibuprofen and risk of Parkinson disease
Xiang Gao et al.
NEUROLOGY (2011)
Neuroinflammation in Parkinson's disease
Etienne C. Hirsch et al.
PARKINSONISM & RELATED DISORDERS (2011)
Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study
Jane A. Driver et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
The differential diagnoses of parkinsonism: Findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics
Renato P. Munhoz et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2010)
Inhibition of I kappa B Kinase-beta Protects Dopamine Neurons Against Lipopolysaccharide-Induced Neurotoxicity
Feng Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Mitochondrial dysfunction: A potential link between neuroinflammation and neurodegeneration?
Maarten E. Witte et al.
MITOCHONDRION (2010)
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
Malu G. Tansey et al.
NEUROBIOLOGY OF DISEASE (2010)
Anti-inflammatory drugs and risk of Parkinson disease A meta-analysis
Joshua J. Gagne et al.
NEUROLOGY (2010)
NSAID Use and the Risk of Parkinson's Disease Systematic Review and Meta-Analysis of Observational Studies
Ali Samii et al.
DRUGS & AGING (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Non-motor features of Parkinson's disease: depression and dementia
Heinz Reichmann et al.
PARKINSONISM & RELATED DISORDERS (2009)
The influence of microglia on the pathogenesis of Parkinson's disease
Caitriona M. Long-Smith et al.
PROGRESS IN NEUROBIOLOGY (2009)
Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease
Maria Clara Pott Godoy et al.
BRAIN (2008)
Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: A retrospective cohort study
Mahyar Etminan et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease
Anamitra Ghosh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease
Angelika D. Wahner et al.
NEUROLOGY (2007)
Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention
Malu G. Tansey et al.
EXPERIMENTAL NEUROLOGY (2007)
Non-steroidal anti-inflammatory drugs in Parkinson's disease
Ennio Esposito et al.
EXPERIMENTAL NEUROLOGY (2007)
The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats
Angela B. Reksidler et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
Marjolijn Bornebroek et al.
NEUROEPIDEMIOLOGY (2007)
Advances in the treatment of Parkinson's disease
Neha Singh et al.
PROGRESS IN NEUROBIOLOGY (2007)
Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: A case-control study
J. H. Bower et al.
NEUROLOGY (2006)
Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats
Marcelo de Meira Santos Lima et al.
BRAIN RESEARCH (2006)
Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease
Thanh G. Ton et al.
MOVEMENT DISORDERS (2006)
Parkinsonism and Parkinson's disease in the elderly: A community-based survey in Brazil (the Bambui study)
Maira Tonidandel Barbosa et al.
MOVEMENT DISORDERS (2006)
Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease
MA Hernán et al.
NEUROLOGY (2006)
NSAID Use and the Risk of Parkinson's Disease
Mahyar Etminan et al.
CURRENT DRUG SAFETY (2006)
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease
HL Chen et al.
ANNALS OF NEUROLOGY (2005)
Neuroinflammatory processes in Parkinson's disease
EC Hirsch et al.
PARKINSONISM & RELATED DISORDERS (2005)
Oxidative stress and inflammation in Parkinson's disease: Is there a causal link?
A Hald et al.
EXPERIMENTAL NEUROLOGY (2005)
Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease
I Kurkowska-Jastrzebska et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2004)
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
HL Chen et al.
ARCHIVES OF NEUROLOGY (2003)
The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-α, IL-1β and IFN-γ
A Castaño et al.
JOURNAL OF NEUROCHEMISTRY (2002)
分享论文
